Veterans' Entitlements (Treatment Principles - Vaccinations for Overseas Travel) Instrument 2010 (No. R40/2010)

Overview

The Veterans’ Entitlements (Treatment Principles – Vaccinations for Overseas Travel) Instrument 2010 was enacted to address a specific gap in the Veterans’ Entitlements Act 1986, which generally governs the financial liability of the Repatriation Commission for the treatment of veterans and their dependants. This legislation was introduced to modify the treatment principles to allow for vaccinations for overseas travel, specifically for Gold Card holders who are eligible for treatment of any injury or disease without the condition needing to be service-related. The Act aims to ensure that these individuals can receive necessary preventive treatments, such as vaccinations, which are crucial for their health when travelling outside Australia. The instrument was enacted by the Repatriation Commission under section 90 of the Veterans’ Entitlements Act 1986 and took effect from 1 August 2010. This change was made to ensure that Gold Card holders are not excluded from receiving necessary vaccinations, thereby enhancing their healthcare coverage while abroad. The policy objective was to extend the eligibility for treatment to include preventive measures, thus improving the overall health and well-being of veterans who travel overseas.

Scope and Application

The Veterans’ Entitlements (Treatment Principles – Vaccinations for Overseas Travel) Instrument 2010 applies to veterans and their dependents who are entitled persons under the Veterans’ Entitlements Act 1986. This legislation, which is a Commonwealth instrument, aims to modify the treatment principles to allow the Repatriation Commission to accept financial liability for vaccinations for overseas travel for Gold Card holders. A Gold Card signifies eligibility for treatment of any injury or disease without it needing to be service-related. The instrument came into effect on 1 August 2010 and allows the Commission to accept responsibility for vaccinations for Gold Card holders who are in Australia at the time of vaccination, provided the vaccination is administered under the Repatriation Pharmaceutical Benefits Scheme. This legislative instrument does not apply to White Card holders, who are only eligible for treatment of service-related injuries or diseases. The Act extends its application through the Veterans’ Entitlements (Vaccinations for Overseas Travel) Eligibility Determination 2010, which was made under section 88A of the Act to facilitate the preventive treatment provision for Gold Card holders.

Key Provisions

The Veterans’ Entitlements (Treatment Principles – Vaccinations for Overseas Travel) Instrument 2010 amends the Treatment Principles set out under section 90 of the Veterans’ Entitlements Act 1986. It modifies the prohibition on the Repatriation Commission accepting financial responsibility for vaccinations for entitled persons planning to travel outside Australia. Specifically, section 4.8.1(k) of Schedule 1 now allows the Commission to accept financial responsibility for the cost of vaccinations for entitled persons who hold a Gold Card and are in Australia at the time the vaccination is provided, provided the vaccination is administered under the Repatriation Pharmaceutical Benefits Scheme. The Act imposes several obligations on the parties it governs. The Repatriation Commission is responsible for ensuring that any vaccinations provided under this amended provision meet the specified criteria, including that the entitled person holds a Gold Card and is physically in Australia at the time of vaccination. The Department of Veterans’ Affairs must issue the Gold Card to eligible persons, confirming their eligibility for treatment of any injury or disease, not necessarily related to service. Entitlement holders must ensure they are in Australia when receiving the vaccination to be eligible for the Commission’s financial responsibility. Breach of the provisions in this instrument may lead to civil or criminal consequences. While specific offences and penalties are not detailed in the explanatory statement, the Act generally provides for penalties for non-compliance with its provisions. These penalties could include fines or other civil sanctions for individuals or entities that do not adhere to the stipulated conditions for vaccinations. The exact nature and extent of penalties would be determined based on the specific breach and the discretion of the relevant authorities under the Act. The instrument is beneficial and commenced on 1 August 2010, prior to its registration on the Federal Register of Legislative Instruments. Importantly, it does not negatively affect any person and therefore does not contravene subsection 12(2) of the Legislative Instruments Act 2003. As the instrument is deemed beneficial, consultation with affected parties was not considered necessary. There are no documents incorporated by reference in this instrument, and further explanations are provided in Attachment A.